PHOENIX, Ariz. — Aug. 22, 2019 — An international team of researchers led by Yale …
Read More »
WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced positive results from the landmark Phase III DAPA-HF trial which …
Read More »
BOONTON, N.J., Aug. 21, 2019 /PRNewswire/ — Enteris BioPharma, Inc., a biotechnology company developing innovative …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
TOKYO and BASKING RIDGE, N.J., April 4, 2019 /PRNewswire/ — Daiichi Sankyo Company, Limited (hereafter, …
Read More »
NEW YORK and CLEVELAND, April 04, 2019 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), …
Read More »
SALT LAKE CITY, April 04, 2019 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader …
Read More »
OXFORD, England & CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, …
Read More »
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading …
Read More »
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced results from pooled analyses of survival data …
Read More »
MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the …
Read More »
BRISBANE, Calif. & NEW YORK–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, and …
Read More »
RAMSEY, N.J. and BOCA RATON, Fla., April 01, 2019 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. announced that data published online today in The Lancet Respiratory …
Read More »
LA JOLLA, Calif., April 01, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded …
Read More »
BOSTON, April 01, 2019 (GLOBE NEWSWIRE) — Ziopharm Oncology, Inc. (Nasdaq: ZIOP), a clinical stage immuno-oncology …
Read More »
WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US (known as MSD outside …
Read More »
BOSTON, April 1, 2019 /PRNewswire/ — IFM Therapeutics (IFM), a privately held biopharmaceutical company focused …
Read More »
ROCKLAND, Mass., March 29, 2019 /PRNewswire/ — EMD Serono, the biopharmaceutical business of Merck KGaA, …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
